220 related articles for article (PubMed ID: 17037786)
1. [Biologic therapy for inflammatory bowel diseases].
Bosques Padilla F
Rev Gastroenterol Mex; 2006 Aug; 71 Suppl 1():91-4. PubMed ID: 17037786
[No Abstract] [Full Text] [Related]
2. [Advances in the use of non-biologic agents in the treatment of inflammatory bowel diseases].
Bosques Padilla F
Rev Gastroenterol Mex; 2006 Aug; 71 Suppl 1():86-90. PubMed ID: 17037785
[No Abstract] [Full Text] [Related]
3. [Immunobiology of chronic inflammatory bowel diseases].
Siegmund B; Zeitz M
Dtsch Med Wochenschr; 2006 Nov; 131(47):2657-60. PubMed ID: 17109275
[No Abstract] [Full Text] [Related]
4. [How long should combined therapy with biological and immunomodulatory agents be maintained in inflammatory bowel disease?].
Domènech E; López San Román A; Garcia-Planella E
Gastroenterol Hepatol; 2010; 33(6):471-2; author reply 472-3. PubMed ID: 20435379
[No Abstract] [Full Text] [Related]
5. [Biological therapy of inflammatory bowel disease].
Lazebnik LB; Parfenov AI; Kniazev OV; Konopliannikov AG; Sagynbaeva VE; Iakovleva MV; Astrelina TA; Ruchkina IN; Shcherbakov PL; Trubitsyna IE; Tsaregorodtseva TM; Gudkova RB; Rogozina VA; Chikunova BZ; Khomeriki SG; Mikhaĭlova ZF
Eksp Klin Gastroenterol; 2011; (2):7-14. PubMed ID: 21560638
[No Abstract] [Full Text] [Related]
6. Anti-tumor necrosis factor therapy for pediatric inflammatory bowel diseases.
Bujanover Y; Weiss B
Isr Med Assoc J; 2008; 10(8-9):634-9. PubMed ID: 18847168
[No Abstract] [Full Text] [Related]
7. Medical therapy of IBD in 2009.
Harris A; Feller ER; Shah SA
Med Health R I; 2009 Mar; 92(3):78-81. PubMed ID: 19385382
[No Abstract] [Full Text] [Related]
8. Risks of combining immunosuppressive and biological treatments in inflammatory bowel disease.
Roblin X; Phelip JM
Arch Intern Med; 2008 Mar; 168(6):667; author reply 667-8. PubMed ID: 18362263
[No Abstract] [Full Text] [Related]
9. Treatment of immune-mediated extraintestinal manifestations of inflammatory bowel disease with infliximab.
Barrie A; Plevy S
Gastroenterol Clin North Am; 2006 Dec; 35(4):883-93. PubMed ID: 17129819
[TBL] [Abstract][Full Text] [Related]
10. Safety of infliximab and other biologic agents in the inflammatory bowel diseases.
Reddy JG; Loftus EV
Gastroenterol Clin North Am; 2006 Dec; 35(4):837-55. PubMed ID: 17129816
[TBL] [Abstract][Full Text] [Related]
11. Use of biologic agents in pediatric inflammatory bowel disease.
Rosh JR
Curr Opin Pediatr; 2009 Oct; 21(5):646-50. PubMed ID: 19629010
[TBL] [Abstract][Full Text] [Related]
12. [American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
Lichtenstein GR; Sbreu MT; Cohen R; Tremaine W
Rev Gastroenterol Mex; 2006; 71(3):351-401. PubMed ID: 17140062
[No Abstract] [Full Text] [Related]
13. [Intestinal inflammation: leading trends and treatment prospects].
Parfenov AI
Ter Arkh; 2007; 79(8):5-9. PubMed ID: 17926462
[No Abstract] [Full Text] [Related]
14. Reply to de Vries HE, Van Oijen MGH, de Jong DJ. Safety of infliximab in inflammatory bowel disease needs to be debated. Clin Gastroenterol Hepatol 2009;7:603-604.
Caspersen S; Mortensen C; Riis L; Jess T; Bendtsen F
Clin Gastroenterol Hepatol; 2009 Nov; 7(11):1257. PubMed ID: 19778634
[No Abstract] [Full Text] [Related]
15. Monoclonal antibody use in inflammatory bowel disease.
Hayes CE; Cerezo CS
Med Health R I; 2011 Nov; 94(11):337-40. PubMed ID: 22204097
[No Abstract] [Full Text] [Related]
16. Drug therapy for inflammatory bowel disease in pregnancy and the puerperium.
Moffatt DC; Bernstein CN
Best Pract Res Clin Gastroenterol; 2007; 21(5):835-47. PubMed ID: 17889811
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppresive therapy for inflammatory bowel disease.
Casis Herce B
Rev Esp Enferm Dig; 2003 Jul; 95(7):456-8, 453-5. PubMed ID: 12952507
[No Abstract] [Full Text] [Related]
18. Safety of infliximab in inflammatory bowel disease needs to be debated.
de Vries HS; Van Oijen MG; de Jong DJ
Clin Gastroenterol Hepatol; 2009 May; 7(5):603-4. PubMed ID: 19166980
[No Abstract] [Full Text] [Related]
19. Treatment with biologic therapies and the risk of cancer in patients with IBD.
Biancone L; Calabrese E; Petruzziello C; Pallone F
Nat Clin Pract Gastroenterol Hepatol; 2007 Feb; 4(2):78-91. PubMed ID: 17268543
[TBL] [Abstract][Full Text] [Related]
20. [Advances in biologic therapy for inflammatory bowel disease].
Sostegni R; Pera A; Daperno M; Rocca R
Recenti Prog Med; 2008 Jan; 99(1):10-8. PubMed ID: 18389866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
